Home >> CAP TODAY Recommends

CAP TODAY Recommends

3rd annual Diagnostic Management Team meeting

The third annual Diagnostic Management Team meeting will be held March 5–6 at the Galveston Island Convention Center, in Galveston, Tex. The focus of the meeting is on the barriers that exist for the rapid and significant growth of diagnostic management teams to reduce medical error and optimize laboratory test use. Barriers include communication and conductivity limitations, insufficient payment for consultation services by the DMT, an inadequate number of individuals able to lead a DMT, and the cultural barriers that prevent established laboratory directors from becoming DMT leaders. The two-day event will feature three diagnostic management teams—microbiology, hematopathology, and platelet refractoriness—and includes speakers, poster presentations, and a panel discussion and will close with a live webinar.

Read More »

Luminex offers white paper on preventing CDI

A white paper titled “Can Global Testing for C. difficile Carriers Help to Prevent Healthcare-associated CDI?” from Luminex discusses the results of two recent studies that show that performing C. difficile testing only in patients with clinically significant diarrhea may be missing an opportunity to prevent CDI transmission from asymptomatic carriers. Download the white paper.

Read More »

Improve triaging in the ED
A new assay delivers a higher standard of cardiac care

Improve triaging in the ED: A new assay delivers a higher standard of cardiac care. “Is it a heart attack, or something less serious?” Every day, thousands of symptomatic patients ask emergency department (ED) physicians that very question. Over the years, as diagnostic tools for acute myocardial infarction (AMI), commonly known as a heart attack, have advanced, physicians can provide increasingly accurate answers to that question. Unfortunately, diagnostic gaps still exist that can result in poor patient outcomes.

Read More »

Digital pathology association stands behind FDA’s approval of marketing whole slide imaging system

April 13, 2017—The Digital Pathology community is in full support of the FDA’s landmark announcement that Philips Whole Slide Imaging (WSI) system, IntelliSite, can be marketed for primary diagnosis. This technology facilitates review of digital surgical pathology slides with remote sign out capabilities, and poses a significant benefit to both pathologists and patients alike.

Read More »

POC testing management and integration

Dec. 2, 2016—A new white paper from Orchard Software titled “Point-of-care Testing: The Great Boom Ahead” discusses the history of POC testing connectivity and shares specific case study savings and improvements associated with the adoption of a POC testing connectivity and management solution. Read the white paper.

Read More »

What pharmacogenomics can make possible

Oct. 5, 2016—Clinical laboratories and pathology groups ought to master the emerging areas of pharmacodynamics and pharmacokinetics that open the door to a more personalized approach to drug prescribing, says a free (registration required) white paper published by Dark Daily. Read. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and ...

Read More »

Learn about molecular testing for M. pneumoniae

Sept. 14, 2016—Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch. In a separate presentation, Vicki Chalker, PhD, head of the respiratory and vaccine-preventable bacteria reference unit of Public Health England’s ...

Read More »

How Zika interferes with normal fetal development

Aug. 29, 2016—An Archives of Pathology & Laboratory Medicine study analyzes evidence from nine postmortem examinations and related studies of fetuses and infants with intrauterine Zika virus infection and microcephaly. Author David A. Schwartz, MD, concludes “the Zika virus has a strong predilection for cells of the fetal central nervous system following vertical transmission.” Read the early online release.

Read More »